Bayer Schering Pharma to expand contraceptive market share
Published: 2007-07-23 06:56:00
Updated: 2007-07-23 06:56:00
Bayer Schering Pharma is gearing up to expand its presence in the domestic contraceptive market by launching a new low-dose oral contraceptive called Yasmin in October, together with Postinor-1, an emergent oral contraceptive pill.
This pill - the best-selling contraceptive worldwide - contai...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
